Trial Profile
A retrospective, observational study of bedaquiline in patients with multi-drug resistant (MDR) tuberculosis
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 16 Feb 2017
Price :
$35
*
At a glance
- Drugs Bedaquiline (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 22 Dec 2016 Results assessing long term outcomes and safety of bedaquiline treatment (n=45) published in the European Respiratory Journal.
- 22 Dec 2016 Status changed from active, no longer recruiting to completed.
- 28 Dec 2015 New trial record